Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Ruthenium (II) complex with curcumin derivative as ligand, and preparation method and application thereof

A technology of curcumin derivatives and complexes, applied in ruthenium organic compounds, compounds containing group 8/9/10/18 elements of the periodic table, drug combinations, etc., can solve low cell uptake and tissue distribution, and clinical application Obstacles, instability and other problems, to achieve the effect of improving hydrolysis stability, simple and convenient preparation method, and good inhibition of activity

Active Publication Date: 2019-10-08
SOUTHEAST UNIV
View PDF2 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, its clinical application has been hampered by its poor water solubility and instability under physiological conditions resulting in extremely low cellular uptake and tissue distribution.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Ruthenium (II) complex with curcumin derivative as ligand, and preparation method and application thereof
  • Ruthenium (II) complex with curcumin derivative as ligand, and preparation method and application thereof
  • Ruthenium (II) complex with curcumin derivative as ligand, and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0053] Synthesis of complex 1:

[0054] Cis-(bpy) 2 RuCl 2 (48.40mg, 0.10mmol), curcumin (368.4mg, 1.0mmol), LiCl (42.0mg, 1.0mmol) in EtOH / H 2 O (30 / 10ml) was mixed, stirred and refluxed for 12h to obtain a black solution, the solvent was removed, and column chromatography DCM:MeOH=10:1 gave a dark brown powder.

[0055] Yield: 52.0%. Black-brown powder. Anal. Calcd (%) for C 41 h 35 ClN 4 o 6 Ru: C 60.33, H 4.32, N 6.86. Found: C 60.18, H 4.37, N 6.97; ESI-MS: m / z [M-Cl] + =781.16; 1 HNMR (600MHz, DMSO-d 6 )δ3.75(s,6H),5.96(s,1H),6.58-6.61(d,2H,J=15.8Hz),6.79-6.81(d,2H,J=8.2Hz),6.88-6.90(m ,2H),6.95-6.97(d,2H,J=15.7Hz),7.11-7.12(m,2H),7.29-7.32(t,2H,J=6.6Hz),7.76-7.80(m,4H), 7.91-7.93(t, 2H, J=7.6Hz), 8.16-8.19(t, 2H, J=7.6Hz), 8.64-8.65(d, 2H, J=5.3Hz), 8.74-8.76(d, 2H, J=8.0Hz), 8.85-8.86(d, 2H, J=8.1Hz); 13 C NMR (150MHz, DMSO-d 6 )δ56.02,101.87,110.68,116.08,122.42,123.97,124.02,126.26,126.39,126.93,127.31,135.44,136.47,137.04,148.39,148.77,149.81,153.23,15...

Embodiment 2

[0057] Synthesis of complex 2:

[0058] Cis-(phen) 2 RuCl 2 (53.2mg, 0.10mmol), curcumin (368.4mg, 1.0mmol), LiCl (42.0mg, 1.0mmol) in EtOH / H 2 O (30 / 10ml) was mixed, stirred and refluxed for 12h to obtain a black solution, the solvent was removed, and column chromatography DCM:MeOH=15:1 gave a dark brown powder.

[0059] Yield: 48.6%. Black-brown powder. Anal. Calcd (%) for C 45 h 35 ClN 4 o 6 Ru: C 62.53, H 4.08, N 6.48. Found: C 62.38, H 4.27, N 6.69; ESI-MS: m / z [M-Cl] + =829.16; 1 HNMR (600MHz, DMSO-d 6 )δ3.73(s,6H),6.05(s,1H),6.58-6.61(d,2H,J=15.9Hz),6.77-6.79(d,2H,J=8.2Hz),6.85-6.86(m ,2H),6.93-6.95(d,2H,J=15.8Hz),7.07(m,2H),7.53-7.55(m,2H),8.01-8.02(d,2H,J=5.1Hz),8.20- 8.22(m,2H),8.28-8.30(d,2H,J=8.8Hz),8.37-8.38(d,2H,J=8.9Hz),8.49-8.50(d,2H,J=8.0Hz),8.84 -8.85(d, 2H, J=8.1Hz), 9.12-9.13(d, 2H, J=5.0Hz), 9.66(m, 2H); 13 CNMR (150MHz, DMSO-d 6 )δ56.03,100.00,101.76,110.81,116.08,122.33,125.34,126.02,126.34,127.31,128.07,128.15,130.30,130.45,134.38,136.06,13...

Embodiment 3

[0061] Synthesis of complex 3:

[0062] [Ru(bpy)(dppn)Cl 2 ] (66.1mg, 0.1mmol), curcumin (368.4mg, 1.0mmol), LiCl (42.0mg, 1.0mmol) in EtOH / H 2 O (30 / 10ml) was mixed, stirred and refluxed for 12h to obtain a black solution, the solvent was removed, and column chromatography DCM:MeOH=15:1 gave a dark brown powder. Yield: 40.5%. Black-brown powder. Anal. Calcd (%) for C 53 h 39 ClN 6 o 6 Ru: C 64.14, H 3.96, N 8.47. Found: C 63.98, H 4.13, N 8.69; ESI-MS: m / z [M-Cl] + =957.21; 1 H NMR (600MHz, DMSO-d 6 )δ3.54(s,3H),3.79(s,3H),6.09(s,1H),6.60-6.61(d,1H,J=8.3Hz),6.69-6.71(d,2H,J=15.9Hz ),6.78-6.82(m,2H),6.94-6.95(m,1H),6.99(m,1H),7.06-7.09(d,1H,J=15.8Hz),7.15-7.17(m,2H), 7.21-7.23(t,1H,J=6.6Hz),7.63(m,2H),7.71-7.72(m,1H),7.83-7.84(d,1H,J=5.6Hz),7.88-7.93(m, 2H),8.09-8.10(m,1H),8.23-8.29(m,4H),8.75-8.77(d,1H,J=8.2Hz),8.84-8.90(m,3H),8.96(m,1H) ,9.03-9.04(d,2H,J=5.2Hz),9.26(m,1H),9.43(s,1H),9.57(s,1H); 13 C NMR(150MHz,DMSO-d6)δ55.70,56.10,102.66,110.86,116.06,116.19,122....

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a ruthenium (II) complex with a curcumin derivative as a ligand, and a preparation method and application thereof. The structures of pharmaceutically acceptable salts and solvates of the ruthenium (II) complex with the curcumin derivative as the ligand are represented by formula I. By the method, the curcumin derivative with a diketone structure is used as the ligand for the first time, and a series of ruthenium (II) complexes are synthesized. The curcumin derivative is coordinately bonded with ruthenium (II), the hydrolytic stability of curcumin of the obtained ruthenium (II) complex is remarkably improved, and the ruthenium (II) complex has remarkable toxicity on several tumor cells; activity tests show that the ruthenium (II) complex has high anti-tumor activityand a potential anti-tumor application prospect; the ruthenium (II) complex has higher anti-tumor activity than the curcumin, cisplatin and the like.

Description

technical field [0001] The invention belongs to the field of anti-tumor ruthenium complexes, in particular to a ruthenium (II) complex with curcumin derivatives as a ligand, a preparation method thereof and a ruthenium (II) complex with curcumin derivatives as a ligand It is used for the preparation of antitumor drugs. Background technique [0002] Curcumin, a diketone polyphenol derived from the rhizome of the herb Curcuma longa, is known for its wide range of medicinal properties, curcumin has antibacterial, anti-inflammatory, antioxidant, antitumor and other biological activity. In terms of anti-tumor, curcumin can be used as an anti-proliferation, anti-metastasis and anti-angiogenesis drug to inhibit canceration and limit tumor growth, and exhibits extremely low toxicity to normal cells. However, their clinical applications are hampered by their poor water solubility and instability under physiological conditions resulting in extremely low cellular uptake and tissue di...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07F15/00A61P35/00A61K31/555
CPCC07F15/0053A61P35/00
Inventor 赵健
Owner SOUTHEAST UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com